Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaStefan Hart, J M Wood(Novartis (Switzerland))Blood Cancer JournalNovember 11, 201110.1038/bcj.2011.43Cited by 109SaveCiteExport RISWatch citationsRelated PapersSB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies|Leukemia|2011|198Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats.|Hypertension|1993|31